These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11605016)

  • 1. Expression of cyclooxygenase-2 in ovarian mature cystic teratomas with malignant transformation.
    Sumi T; Ishiko O; Yoshida H; Hyun Y; Nakagawa E; Hirai K; Matsumoto Y; Ogita S
    Int J Mol Med; 2001 Nov; 8(5):495-8. PubMed ID: 11605016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms.
    Matsumoto Y; Ishiko O; Deguchi M; Nakagawa E; Ogita S
    Int J Mol Med; 2001 Jul; 8(1):31-6. PubMed ID: 11408945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation rate and p53, and p16 expression in teratomatous skin of ovarian mature cystic teratoma.
    Zhu HL; Zou ZN; Lin PX; Li WX; Huang YE; Shi XX; Shen H
    Asian Pac J Cancer Prev; 2015; 16(3):1165-8. PubMed ID: 25735349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT findings of mature cystic teratoma with malignant transformation: comparison with mature cystic teratoma.
    Park SB; Cho KS; Kim JK
    Clin Imaging; 2011; 35(4):294-300. PubMed ID: 21724123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.
    Gupta RA; Tejada LV; Tong BJ; Das SK; Morrow JD; Dey SK; DuBois RN
    Cancer Res; 2003 Mar; 63(5):906-11. PubMed ID: 12615701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian teratomas with florid benign vascular proliferation: a distinctive finding associated with the neural component of teratomas that may be confused with a vascular neoplasm.
    Baker PM; Rosai J; Young RH
    Int J Gynecol Pathol; 2002 Jan; 21(1):16-21. PubMed ID: 11781518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 expression in an adenoid cystic carcinoma of the uterine cervix.
    Ishiko O; Sumi T; Yoshida H; Tokuyama O; Wakasa K; Haba T; Ogita S
    Oncol Rep; 2001; 8(5):1023-5. PubMed ID: 11496309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Frequency of Malignant Transformation of Ovarian Mature Teratoma into Squamous Cell Carcinoma in Young Patients in Northeast Brazil.
    Araujo IB; Pinheiro MV; Zanvettor PH; Studart EJ; Filho DF; Coupland SE
    Int J Gynecol Pathol; 2016 Mar; 35(2):176-84. PubMed ID: 26367783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare Skin Adnexal and Melanocytic Tumors Arising in Ovarian Mature Cystic Teratomas: A Report of 3 Cases and Review of the Literature.
    Moulla AA; Magdy N; Francis N; Taube J; Ronnett BM; El-Bahrawy M
    Int J Gynecol Pathol; 2016 Sep; 35(5):448-55. PubMed ID: 26974995
    [TBL] [Abstract][Full Text] [Related]  

    Khachatryan A
    Georgian Med News; 2016 Nov; (Issue):22-28. PubMed ID: 28009311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of IMP3 between male and female mature teratomas--immunohistochemical evidence of malignant nature.
    Goodman S; Zhang L; Cheng L; Jiang Z
    Histopathology; 2014 Oct; 65(4):483-9. PubMed ID: 24605891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvaginal color Doppler ultrasonic characterization of benign and malignant ovarian cystic teratomas and comparison with serum squamous cell carcinoma antigen.
    Emoto M; Obama H; Horiuchi S; Miyakawa T; Kawarabayashi T
    Cancer; 2000 May; 88(10):2298-304. PubMed ID: 10820352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
    Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
    Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium.
    Li S; Miner K; Fannin R; Carl Barrett J; Davis BJ
    Gynecol Oncol; 2004 Feb; 92(2):622-7. PubMed ID: 14766256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.
    Seo SS; Song YS; Kang DH; Park IA; Bang YJ; Kang SB; Lee HP
    Gynecol Oncol; 2004 Mar; 92(3):927-35. PubMed ID: 14984962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
    Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
    J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of 20 mature ovarian cystic teratoma cases in postmenopausal women.
    Wei F; Jiang Z; Yan C
    Chin Med J (Engl); 2001 Feb; 114(2):137-8. PubMed ID: 11780192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare case report of squamous-cell carcinoma arising from mature cystic teratoma of ovary.
    Kalampokas E; Boutas I; Kairi-Vasilatou E; Salakos N; Panoulis K; Aravantinos L; Damaskos C; Kalampokas T; Deligeoroglou E
    G Chir; 2014; 35(9-10):241-5. PubMed ID: 25419592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.